We expect Careium’s positive organic momentum to be maintained in Q3/26, although at a slower pace q/q. The absence of any announcement of a large order in the new Swedish framework makes us assume a combination of tougher competition and inflows of smaller orders. The shares trade at a 2027E EV/EBITA of c. 8x. We adjust our fair value range to SEK 22-32.
LÄS MER
